Back
Quanex Building Products Vs. ANI Pharmaceuticals Industry Stock Comparison
Sell
34
NX
Quanex Building Products
Last Price:
28.50
Seasonality Move:
3.11%
Buy
53
ANIP
ANI Pharmaceuticals
Last Price:
60.82
Seasonality Move:
0.29%
Sell
34
Quanex Building Products (NX)
is a Sell
Is Quanex Building Products a Buy, Sell or Hold?
- The current Quanex Building Products [NX] share price is $28.28. The Score for NX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- NX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
ANI Pharmaceuticals (ANIP)
is a Buy
Is ANI Pharmaceuticals a Buy, Sell or Hold?
- The current ANI Pharmaceuticals [ANIP] share price is $61.05. The Score for ANIP is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- ANIP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
NX Stock Price Chart
What is Quanex Building Products's stock price today?
-
The Quanex Building Products share price today is $28.28
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NX is experiencing selling pressure, which indicates risk of future bearish movement.
ANIP Stock Price Chart
What is ANI Pharmaceuticals's stock price today?
-
The ANI Pharmaceuticals share price today is $61.05
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ANIP is experiencing slight selling pressure.
NX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 52.72 | Buy |
| Chaikin Money Flow: | -469835 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.23 - 28.53) | Buy |
| Bollinger Bands (100): | (27.1 - 32.86) | Sell |
ANIP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 52.65 | Buy |
| Chaikin Money Flow: | -163397 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (57.84 - 62.92) | Buy |
| Bollinger Bands (100): | (59.73 - 65.45) | Sell |
NX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.25 | Buy |
| 20-day SMA: | 27.39 | Buy |
| 50-day SMA: | 28.74 | Sell |
| 200-day SMA: | 31.75 | Sell |
| 8-day EMA: | 27.58 | Buy |
| 20-day EMA: | 27.53 | Buy |
| 50-day EMA: | 28.37 | Sell |
| 200-day EMA: | 30.07 | Sell |
ANIP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.54 | Buy |
| 20-day SMA: | 60.34 | Buy |
| 50-day SMA: | 61.2 | Sell |
| 200-day SMA: | 61.23 | Sell |
| 8-day EMA: | 58.88 | Buy |
| 20-day EMA: | 59.62 | Buy |
| 50-day EMA: | 60.85 | Buy |
| 200-day EMA: | 60.54 | Buy |
Quanex Building Products Earnings Growth & NX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.19 per share, a decrease this year of $0.34 per share, and an increase next year of $0.35 per share.
ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.40 per share, an increase this year of $0.29 per share, and an increase next year of $0.99 per share.
Quanex Building Products Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ANI Pharmaceuticals Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||